Akebia Therapeutics, Inc. (FRA:AX9)
Germany · Delayed Price · Currency is EUR 1.350
+0.004 (0.30%)
At close: Dec 1, 2025
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of €344.68 million as of December 2, 2025. Its market cap has decreased by -12.98% in one year.
Market Cap
344.68M
Enterprise Value
372.70M
Revenue
191.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.35
Market Cap Chart
Since March 21, 2014, Akebia Therapeutics's market cap has increased from 331.28M to 344.68M, an increase of 4.05%. That is a compound annual growth rate of 0.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 344.68M | -13.92% |
| Dec 31, 2024 | 400.41M | 89.46% |
| Dec 29, 2023 | 211.34M | 112.79% |
| Dec 30, 2022 | 99.32M | -71.43% |
| Dec 31, 2021 | 347.68M | 5.09% |
| Dec 31, 2020 | 330.85M | -50.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |